Daewoong Pharmaceutical and Seeus, First in Korea to Obtain ECG Insurance Reimbursement... "Expecting Hospital Efficiency Improvement"

thynC ECG Measurement System: Half the Price and One-Fifth the Weight of Philips
Improved Convenience for Patients and Nurses... Enhanced Hospital Efficiency

On the 3rd, at the JW Marriott Hotel in Dongdaemun-gu, Seoul, speakers are conducting a Q&A session after presentations at Daewoong Pharmaceutical's 'Real-time Hospitalized Patient Monitoring System Think Domestic First ECG Surveillance Insurance Fee Acquisition Press Conference.' From the left in the photo: Byungha Cho, Head of Marketing Division at Daewoong Pharmaceutical; Hongui Lim, Professor of Cardiology at Gwangmyeong Hospital, Chung-Ang University; Youngshin Lee, CEO of Seers Technology; Daeyeop Kang, Vice President of Seers Technology. Photo by Daewoong Pharmaceutical

"I learned for the first time in my 30 years as a physician that the existing Philips electrocardiogram (ECG) measurement system algorithm was flawed. Because it calculated including 'signal loss' caused by patient movement or shifting, it couldn't obtain accurate values. However, the ECG measurement system of thynC, developed by Daewoong Pharmaceutical and Seeas Technology, excluded the loss values and provided more accurate data."

Professor Lim Hong-ui of the Cardiology Department at Chung-Ang University Gwangmyeong Hospital stated this on the 3rd at Daewoong Pharmaceutical's 'Press Conference for the First Domestic ECG Monitoring Insurance Reimbursement Acquisition for the Real-Time Hospitalized Patient Monitoring System thynC' held at JW Marriott Dongdaemun Square in Seoul.

thynC Diagnoses and Tracks Patients While Worn... "Hospital Efficiency Will Improve"

thynC, developed by Daewoong Pharmaceutical, is a service where wearable biosensors measure patients' vital signs such as ECG, body temperature, oxygen saturation, and blood pressure, analyze them using AI (artificial intelligence) algorithms, and deliver the results to medical staff. This thynC system integrates various healthcare devices from different companies, including the wearable ECG device 'MobiCare' (Seeas Technology), the continuous glucose monitor 'FreeStyle Libre' (Abbott), and the ring-type continuous blood pressure monitor 'CartBP' (SkyLabs), expanding the ecosystem.

Jo Byung-ha, Head of Marketing at Daewoong Pharmaceutical, who announced Daewoong's digital healthcare vision, said, "The past method of going to the hospital for tests and treatment when sick is evolving into a direction where diseases are predicted and managed in advance using accumulated health data. Daewoong Pharmaceutical is introducing and distributing innovative data-driven health management solutions in line with this change, aiming to realize personalized health management and contribute to improving public health."

Professor Lim Hong-ui of the Department of Cardiology at Chung-Ang University Gwangmyeong Hospital is explaining the clinical results of Think. Photo by Daewoong Pharmaceutical

Professor Lim presented the limitations of existing ECG measurement devices he experienced over 30 years in medical practice and the convenience of the thynC system. He evaluated that thynC's signal quality is superior to Philips' system, which currently dominates the domestic market. Professor Lim conducted an experiment comparing arrhythmia detection rates, signal quality (signal noise, loss ratio), and other factors between Philips' system and thynC on 80 patients.

Professor Lim said, "Philips' system attaches five patches to the patient's body, and every time the patient moves, the wires rub, creating 'signal noise.' In contrast, thynC uses patches weighing less than 100g, significantly reducing signal noise and loss ratio." He also predicted that the introduction of thynC would improve hospital efficiency. "More than 60% of nurses' tasks involve checking patients' vitals and entering them into the management system. The thynC system reduces such inefficiencies and provides a real-time monitoring system, allowing nurses to focus more on patient care," he said. The industry estimates that thynC's streamlined system is priced at about half that of Philips.

thynC, Which Acquired ECG Insurance Reimbursement, Expands Ecosystem to Blood Pressure and Blood Sugar

At the media briefing, Lee Young-shin, CEO of Seeas Technology, said, "thynC especially detects cardiac arrest, sepsis, and falls, providing early warnings that enable immediate response, thereby enhancing patient safety. In the current situation of shortages of residents and nurses, it will play an important role in improving efficiency and quality of patient management in medical settings."

He continued, "Medical institutions can now actively adopt thynC, increasing patient management efficiency and establishing a foundation to provide better treatment environments. This insurance reimbursement acquisition is an important milestone recognizing thynC's technological capabilities," he said.

Lee Young-shin, CEO of Seers Technology, is explaining Think at a press conference. Photo by Daewoong Pharmaceutical

Daewoong Pharmaceutical plans to link SkyLabs' ring-type continuous blood pressure monitor 'CartBP' to thynC within the first half of this year, leveraging the insurance reimbursement acquisition of Seeas Technology's thynC. Through this, they aim to further expand digital healthcare technology and accelerate the establishment of a smart medical environment.

Regarding this, Jo Byung-ha, Head of Marketing at Daewoong Pharmaceutical, said, "Currently, thynC is used in 10 hospitals, and we plan to expand supply not only to tertiary general hospitals but also to secondary general hospitals. We will do our best to optimize inpatient health management across various departments such as cardiology, neurology, pulmonology, surgery, emergency medicine, and oncology wards, enabling medical staff to manage patients more efficiently."

Regarding thynC's insurance reimbursement acquisition, Daewoong Pharmaceutical CEO Lee Chang-jae said, "Last year, South Korea entered a super-aged society where over 20% of the population is aged 65 or older. As life expectancy increases, not only disease treatment but also routine management, prevention, and prediction have become very important. Based on digital healthcare innovation, we will build a comprehensive healthcare ecosystem encompassing data-driven disease prediction, prevention, treatment, and post-care, enhancing patient-tailored health management and the quality of medical services to contribute to public health," he stated.